Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L31 pseudogene 47 (RPL31P47) is a processed pseudogene located in the human genome. It is named based on its homology to ribosomal protein L31 but does not encode a functional ribosomal protein. Like many other ribosomal protein pseudogenes, RPL31P47 arose through gene duplication and retrotransposition events. It does not produce a functional protein and is not involved in biological processes or diseases, distinguishing it from its parent gene RPL31, which is a part of the ribosomal 60S subunit and is implicated in protein synthesis[1][7][9][10]. Key distinction: - RPL31P47 is not an active gene or therapeutic target; the canonical ribosomal protein L31 (RPL31) is the active ribosomal protein but is unrelated to the therapeutic targeting of receptors, enzymes, or druggable molecules[5][6]. - The presence of 'pseudogene' in the canonical name confirms its non-functional status in cellular biology and therapeutic contexts[1][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L31 pseudogene 47 (RPL31P47).